{"organizations": [], "uuid": "f7c2b2521020ef123fcf0198d655b69276e865a7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180501.html", "section_title": "Archive News &amp; Video for Tuesday, 01 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/samsung-biologic-accounting-samsung-ct-c/samsung-biologics-shares-plunge-after-regulator-says-co-breached-accounting-rules-idUSS6N1R203R", "country": "US", "domain_rank": 408, "title": "Samsung BioLogics shares plunge after regulator says co breached accounting rules", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-02T08:19:00.000+03:00", "replies_count": 0, "uuid": "f7c2b2521020ef123fcf0198d655b69276e865a7"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/samsung-biologic-accounting-samsung-ct-c/samsung-biologics-shares-plunge-after-regulator-says-co-breached-accounting-rules-idUSS6N1R203R", "ord_in_thread": 0, "title": "Samsung BioLogics shares plunge after regulator says co breached accounting rules", "locations": [], "entities": {"persons": [{"name": "sou", "sentiment": "negative"}, {"name": "stephen coates", "sentiment": "none"}, {"name": "joyce lee", "sentiment": "none"}], "locations": [{"name": "seoul", "sentiment": "none"}, {"name": "korea", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "samsung biologics", "sentiment": "negative"}, {"name": "samsung biologics co ltd", "sentiment": "negative"}, {"name": "financial supervisory service", "sentiment": "none"}, {"name": "samsung c&t corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SEOUL, May 2 (Reuters) - Shares in Samsung BioLogics Co Ltd fell over 18 percent on Wednesday as South Koreaâ€™s watchdog Financial Supervisory Service provisionally decided it had breached accounting rules.\nShares in Samsung C&T Corp, which holds a 43 percent stake in drug contract manufacturer Samsung BioLogics, also fell more than 5 percent.\nSamsung BioLogics said in a regulatory filing that it will prove it had engaged in proper accounting practices. (Reporting by Joyce Lee; Editing by Stephen Coates)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-02T08:19:00.000+03:00", "crawled": "2018-05-02T16:21:54.019+03:00", "highlightTitle": ""}